Trial Profile
Safety and Efficacy of Bivalirudin in Patients With Diabetes Mellitus Undergoing Percutaneous Coronary Intervention (PCI)
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 14 Aug 2020
Price :
$35
*
At a glance
- Drugs Bivalirudin (Primary) ; Heparin
- Indications Acute coronary syndromes
- Focus Therapeutic Use
- 20 Aug 2018 Planned initiation date changed from 30 Jul 2018 to 15 Sep 2018.
- 28 Jun 2018 New trial record